EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms

Colette Hanna, Joe Rizkallah, Nicole Charbel, Shereen Sakkal, Fadi G Haddad

Current Hematologic Malignancy Reports · 07.03.2026 · 21 (1)

DOI: 10.1007/s11899-026-00775-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Hematologic Malignancy Reports, online erschienen am 07.03.2026. Verfasst von Colette Hanna und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon. Hauptthemen laut MEDLINE: Hypereosinophilic Syndrome, Molecular Targeted Therapy, Myeloproliferative Disorders. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypereosinophilic SyndromeMolecular Targeted TherapyMyeloproliferative DisordersHumansProtein Kinase InhibitorsAntineoplastic Agents

Stichwörter der Autor:innen

FGFR1 rearrangementFIP1L1-PDGFRAHypereosinophilic syndromeMyeloid/Lymphoid neoplasms with eosinophiliaTyrosine kinase inhibitors

Substanzen

Protein Kinase InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Division of Hematology/Oncology, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon.
  • Department of Diagnostic Radiology, American University of Beirut, Beirut, Lebanon.
  • Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
  • Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
  • Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. fhaddad@mdanderson.org.

Zitieren

APA

Hanna, C., Rizkallah, J., Charbel, N., Sakkal, S., & Haddad, F. G. (2026). Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms. Current Hematologic Malignancy Reports, 21(1). https://doi.org/10.1007/s11899-026-00775-4

Vancouver

Hanna C, Rizkallah J, Charbel N, Sakkal S, Haddad FG. Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms. Current Hematologic Malignancy Reports. 2026;21(1). doi:10.1007/s11899-026-00775-4

BibTeX
@article{Hanna2026,
  author = {Hanna, Colette and Rizkallah, Joe and Charbel, Nicole and Sakkal, Shereen and Haddad, Fadi G},
  title = {Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms},
  journal = {Current Hematologic Malignancy Reports},
  year = {2026},
  volume = {21},
  number = {1},
  doi = {10.1007/s11899-026-00775-4}
}
Kostenlos starten →